Skip to main content

IN CASE YOU MISSED IT: NBC Nightly News Features Nephron Educator Program

WEST COLUMBIA, S.C. – Wednesday night’s broadcast of NBC Nightly News with Lester Holt featured a segment that highlighted Nephron Pharmaceuticals Corporation’s educator program. The program employs more than 650 teachers.

Participants in the educator program assist Nephron’s more than 1,000 full-time employees, giving these teachers the opportunity to earn secondary income.

Watch the NBC Nightly News segment here.

“We are grateful for our teachers, we are proud of how hard they work with our children and at Nephron, and we hope other companies across S.C. will join us in supporting them in and out of the classroom,” said Nephron Pharmaceuticals Company CEO Lou Kennedy.
 
Nephron announced the educator program earlier this year. The mission of the program is to provide secondary income to educators as they help Nephron fill and complete orders.
 
Educators are focused specifically on the Nephron 503B outsourcing division which services U.S. hospitals and surgery centers with drug shortage needs.  Nephron is able to complete orders faster with the support of these teachers and administrators.

About Nephron Pharmaceuticals

Nephron 503B Outsourcing is a division of Nephron Pharmaceuticals Corporation. This division produces pre-filled sterile syringes and IV bags for hospitals across America, in an effort to alleviate their drug shortage needs. In accordance with the DQSA draft guidance, the company follows cGMP, GDP and all quality expectations. The company has been licensed by the Food and Drug Administration as a sterile manufacturer of generic respiratory medications along with an Outsourcing Facility providing equal sterility and quality. Nephron received a 2017 ISPE/FOYA innovation award for the high level of automation present throughout the facility. For more information, please visit www.nephronpharm.com.

Nephron Interns Selected To Participate in ASHP Presentations about Process Improvements in Pharmaceutical Manufacturing

WEST COLUMBIA, S.C. – Nephron Pharmaceuticals Corporation today announced that six teams of its interns, all of whom are students at the University of South Carolina’s College of Pharmacy, have been selected from among competitors across the country to deliver poster presentations at American Society of Health-System Pharmacists Midyear Clinical Meeting and Exhibition (ASHP). 

ASHP Midyear meeting is the largest gathering of pharmacists in the world with more than 25,000 pharmacists from many countries in attendance. Poster Presentations are discussions among meeting attendees about current projects in pharmacy practice.  Poster presentations provide an excellent opportunity to exchange ideas that have been successful in other healthcare systems.

“Nephron interns are among the brightest rising stars in pharmaceutical manufacturing,” said Nephron CEO Lou Kennedy. “The work they are doing for Nephron has played a critical role in our growth, and we are proud that they will share their work with industry experts and leaders.”

The titles of the projects by Nephron interns that have all been accepted by ASHP include:

•    College of Pharmacy and School of Engineering Student Teams’ collaboration to design pharmacy compounding system using robotic arm to perform aseptic syringe filling.

•    Performance comparison of the Baxter repeater pump and the Masterflex peristaltic pump using high flow tubing set L/S 24.

•    Development of the Masterflex L/S peristaltic pump process validation in a 503B outsourcing pharmacy.

•    Evaluation of naloxone safety training effectiveness in a workplace environment.

•    Evaluation of cleaning effectiveness of 7.8% ionized hydrogen peroxide mist versus 7.8% hydrogen peroxide mist in a cleanroom environment.

ASHP represents pharmacists who serve as patient care providers in acute and ambulatory settings. The organization’s nearly 50,000 members include pharmacists, student pharmacists, and pharmacy technicians. For more than 75 years, ASHP has been at the forefront of efforts to improve medication use and enhance patient safety.

About Nephron Pharmaceuticals

Nephron 503B Outsourcing is a division of Nephron Pharmaceuticals Corporation. This division produces pre-filled sterile syringes and IV bags for hospitals across America, in an effort to alleviate their drug shortage needs. In accordance with the DQSA draft guidance, the company follows cGMP, GDP and all quality expectations. The company has been licensed by the Food and Drug Administration as a sterile manufacturer of generic respiratory medications along with an Outsourcing Facility providing equal sterility and quality. Nephron received a 2017 ISPE/FOYA innovation award for the high level of automation present throughout the facility. For more information, please visit www.nephronpharm.com.
 

A Conversation with Sam Konduros and Lou Kennedy, SCBIO

October 3, 2019 – There is tremendous momentum in the life sciences in South Carolina. It is now the fastest growing segment of the innovation economy in the state with 678 life sciences companies.

WATCH VIDEO.

October 29-31, SCBIO is hosting SCBIO 2019, one of the Southeast’s premier life sciences conferences, showcasing leadership in innovation and advancement from pharma and medtech to biomaterials, bio-ag and health IT. The conference brings to life how we are improving the health and well-being of our people and environment while catalyzing our economy.

SCBIO is a statewide, not-for-profit, public/private life sciences industry association and economic development organization formed to actively promote, build and support South Carolina’s life sciences industry. SCBIO is the official state affiliate of BIO – the U.S. Biotechnology Innovation Organization. BIO champions biotechnology and its potential to provide better healthcare, enhanced agriculture, and a cleaner and safer environment for people around the world.

Contact Us